# US 2012/0251489 A1 · Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251489 A1
- Document ID: US20120251489A1
- Status: Published application
- Kind: A1
- Application number: 13/514,719
- Filed: 2010-12-07
- Published: 2012-10-04
- Earliest claimed: 2009-12-09
- Assignees: Fresenius Medical Care Deutschland GmbH
- Inventors: Maria Beatriz Herrera Sanchez; Valentina Fonsato; Ciro Tetta; Giovanni Camussi
- Web page: https://patentgrep.com/patent/US20120251489A1

## CPC

- C12N 5/0672: {Stem cells; Progenitor cells; Precursor cells; Oval cells}
- A61K 35/28: Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A61K 35/35: Fat tissue; Adipocytes; Stromal cells; Connective tissues (adipose-derived stem cells A61K35/28; collagen A61K38/39)
- A61P 35/00: Antineoplastic agents
- C12N 2500/84: from mammals
- C12N 2501/11: Epidermal growth factor [EGF]
- C12N 2501/39: Steroid hormones
- C12N 2502/14: hepatocytes
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention is in the field of therapeutic treatment of tumours. It has been found that the conditioned medium resulting from culturing an adult stem cell capable of differentiating into a plurality of differentiated cell types in a liquid cell culture medium and/or the adult stem cell from which the conditioned medium is obtainable, exert a remarkable anti-tumour effect. The adult stem cell derived conditioned medium preferred in this therapeutic application is a cell free conditioned medium derived from a human liver stem cell (HLSC).

## Claims

### Claim 1

A conditioned medium which comprises a plurality of cell-secreted proteins and which is obtainable by culturing in a liquid cell culture medium an adult stem cell capable of differentiating into a plurality of differentiated cell types, for use in the therapeutic treatment of a tumour disease.

### Claim 2 (depends on 1)

The conditioned medium according to claim 1, which comprises a cell fraction consisting of the adult stem cell from which the conditioned medium is obtainable.

### Claim 3 (depends on 1)

The conditioned medium according to claim 1, which is cell free.

### Claim 4 (depends on 3)

The conditioned medium according to claim 3, which is obtainable by a method comprising the steps of:
(i) culturing an adult stem cell capable of differentiating into a plurality of differentiated cell types in a liquid cell culture medium for a predetermined period of time; and
(ii) removing the cell fraction from the liquid cell culture medium, thereby obtaining a cell free conditioned medium which comprises a plurality of cell-secreted proteins.

### Claim 5 (depends on 4)

The conditioned medium according to claim 4, wherein the cell fraction is removed from the liquid cell culture medium by centrifugation or filtration.

### Claim 6 (depends on 5)

The conditioned medium according to claim 5, wherein the liquid cell culture medium is additionally subjected to ultracentrifugation at a g-force comprised between about 20,000 and 300,000 g, preferably between about 80,000 and 200,000 g.

### Claim 7 (depends on 4)

The conditioned medium according to claim 4, wherein the method further comprises the step of:
(iii) removing from the cell free conditioned medium the fraction of matter having a nominal molecular weight lower than 3 kDa.

### Claim 8 (depends on 7)

The conditioned medium according to claim 7, wherein the fraction of matter having a nominal molecular weight lower than 3 kDa is removed from the cell free conditioned medium by ultrafiltration.

### Claim 9 (depends on 4)

The conditioned medium according to claim 4, wherein the method further comprises the step of treating the cell free conditioned medium obtained in step (ii) or in step (iii) with RNase.

### Claim 10 (depends on 1)

The conditioned medium according to claim 1, wherein the adult stem cell capable of differentiating into a plurality of differentiated cell types is selected from the group consisting of liver stem cell, renal stem cell, adipose stem cell, mesenchymal stem cell, perivascular multipotent progenitor cell, dental pulp stem cell, epithelial stem cell, hematopoietic stem cell, stem cell from exfoliated deciduous teeth and umbilical cord stem cell.

### Claim 11 (depends on 10)

The conditioned medium according to claim 10, wherein the adult stem cell capable of differentiating into a plurality of differentiated cell types is a non-oval liver stem cell.

### Claim 12 (depends on 11)

The conditioned medium according to claim 11, wherein the non-oval liver stem cell is capable of differentiating into a mature liver cell, an insulin-producing cell, an osteogenic cell and an epithelial cell.

### Claim 13 (depends on 1)

The conditioned medium according to claim 1, wherein the adult stem cell capable of differentiating into a plurality of differentiated cell types is a human cell.

### Claim 14

An adult stem cell capable of differentiating into a plurality of differentiated cell types, for use in the therapeutic treatment of a tumour disease.

### Claim 15 (depends on 10)

An adult stem cell capable of differentiating into a plurality of differentiated cell types for use in the therapeutic treatment of a tumour disease, which is as defined in claim 10.

### Claim 16 (depends on 1)

The conditioned medium according to claim 1 or the adult stem cell capable of differentiating into a plurality of differentiated cell types for use in the therapeutic treatment of a tumour disease, wherein the tumour disease is a solid tumour.

### Claim 17 (depends on 16)

The conditioned medium or the adult stem cell according to claim 16, wherein the tumour disease is selected from the group comprising liver tumour, epithelial tumour, breast tumour, lung tumour, prostate tumour, gastric tumour, colon tumour.

### Claim 18 (depends on 17)

The conditioned medium or the adult stem cell according to claim 17, wherein the tumour disease is selected from the group comprising hepatoma, Kaposi's sarcoma and breast adenocarcinoma.

### Claim 19 (depends on 1)

The use of a conditioned medium according to claim 1 or of an adult stem cell capable of differentiating into a plurality of differentiated cell types for use in the therapeutic treatment of a tumour disease, for preparing a medicament for the therapeutic treatment of a tumour disease.

### Claim 20 (depends on 19)

The use according to claim 19, wherein the tumour disease is a solid tumour.

### Claim 21 (depends on 19)

The use according to claim 19, wherein the medicament is for local or systemic administration.

### Claim 22 (depends on 21)

The use according to claim 21, wherein the medicament is for administration by injection.
